University of Rochester Adult HIV Therapeutic Strategies Network CRS (Site # 31787) — Rochester, New York

University of Rochester Adult HIV Therapeutic Strategies Network CRS (Site # 31787) is a clinical research site located in Rochester, New York, United States 14642.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

University of Rochester Adult HIV Therapeutic Strategies Network CRS (Site # 31787) has participated in 1 clinical trials.

Therapeutic areas: HIV-1-infection, Elevated Cardiovascular Risk.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Rochester Adult HIV Therapeutic Strategies Network CRS (Site # 31787)?

University of Rochester Adult HIV Therapeutic Strategies Network CRS (Site # 31787) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Rochester Adult HIV Therapeutic Strategies Network CRS (Site # 31787) conducted?

University of Rochester Adult HIV Therapeutic Strategies Network CRS (Site # 31787) has 1 clinical trials on record. Their work covers HIV-1-infection, Elevated Cardiovascular Risk.

Is University of Rochester Adult HIV Therapeutic Strategies Network CRS (Site # 31787) accredited by Crixeo Health?

University of Rochester Adult HIV Therapeutic Strategies Network CRS (Site # 31787) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Rochester Adult HIV Therapeutic Strategies Network CRS (Site # 31787)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.